What causes type 1 diabetes?
The exact cause of type 1 diabetes is not known, but it is thought to be an autoimmune disease. Autoimmune diseases are those in which the body's immune system attacks and destroys its own tissue — in this case, the cells in the pancreas that make insulin (called islet cells). This means that the pancreas makes little or no insulin, resulting in higher than normal blood glucose levels (more than 8 millimoles [mmol] of glucose per litre [L] of blood).
Type 1 diabetes usually runs in families, so if you have a close relative (a parent, brother or sister) with type 1 diabetes, you are more likely to develop it compared with someone who is not related to anyone with type 1 diabetes. This means that there may be a genetic cause for why the body’s immune system attacks the pancreas in type 1 diabetes.
- Craig ME, Twigg SM, Donaghue KC, et al for the Australian Type 1 Diabetes Guidelines Expert Advisory Group. National evidence-based clinical care guidelines for type 1 diabetes in children, adolescents and adults. Canberra: Australian Government Department of Health and Ageing, 2011. www.diabetessociety.com.au/downloads/ Type1guidelines14Nov2011.pdf (accessed 15 November 2011).
- Type 2 diabetes: priorities and targets. NPS NEWS (www.nps.org.au/health_professionals/publications/nps_news/current/type_2_diabetes_priorities_targets)
- Yudkin JS, Richter B, Gale EA. Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia 2010;53:2079–85.
- Turnbull FM, Abraira C, Anderson RJ, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009;52:2288–98.
- Kearney PM, Blackwell L, Collins R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008;371:117–25.
- Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.